Evidence map›Paper›PMID 23946894›Full record

ArticleJournal of clinical & cellular immunology2012

T cell Receptor Signal Transduction in T lymphocytes.

Balachandra K Gorentla, Xiao-Ping Zhong

Abstract read
In one paragraph

Article in Journal of clinical & cellular immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Degron-based bioPROTACs for controlling signaling in CAR T cells.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Novel peptide-based inhibitor for targeted inhibition of T cell function.Journal of cell communication and signaling · 2022
    Article
  13. IL-6 Responsiveness of CD4Journal of clinical medicine · 2022
    Article
  14. Article
  15. T cell receptor (TCR) signaling in health and disease.Signal transduction and targeted therapy · 2021
    Review
  16. Review
  17. Review
  18. CD4Frontiers in immunology · 2020
    Article
  19. Intracellular KScientific reports · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Balachandra K GorentlaPediatric Biology Center, Translational Health Science and Technology Institute, Gurgaon, 122016, India.
Xiao-Ping Zhong
Translational Health Science and Technology Institute · IN

Funding

Regulation of peripheral T cell toleranceR01AI079088 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2008 to 2019
$3.5M
TSC1-mTOR signaling and T cell toleranceR01AI101206 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2012 to 2016
$1.9M
A Murine Model of Chronic Autoimmune Hepatitis and Liver FibrosisR01AI076357 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2008 to 2012
$1.5M
Immunotherapy for Peanut AllergyR21AI079873 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2008 to 2009
$422k
NIAID NIH HHS R01 AI076357NIAID NIH HHS R01 AI079088NIAID NIH HHS R01 AI101206NIAID NIH HHS R21 AI079873
6 · The paper itself

Abstract

The T cell receptor (TCR) recognizes self or foreign antigens presented by major histocompatibility complex (MHC) molecules. Engagement of the TCR triggers the formation of multi-molecular signalosomes that lead to the generation of second messengers and subsequent activation of multiple distal signaling cascades, such as the Ca

Indexed as

Diacylglycerol kinaseMammalian target of rapamycinT cell activationT cell anergyT cell developmentT cell receptorT cell tolerance

Identifiers

PMID23946894
PMCPMC3740441
OpenAlexW100848711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.